A citation-based method for searching scientific literature

Mai Elezaby, Brittany Lees, Katherine E Maturen, Lisa Barroilhet, Kari B Wisinski, Sarina Schrager, Lee G Wilke, Elizabeth Sadowski. Radiology 2019
Times Cited: 14







List of co-cited articles
39 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018
207
28

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
491
21

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
731
21

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
K Passaperuma, E Warner, P A Causer, K A Hill, S Messner, J W Wong, R A Jong, F C Wright, M J Yaffe, E A Ramsay,[...]. Br J Cancer 2012
110
21

Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
Kala Visvanathan, Patricia Shaw, Betty J May, Asli Bahadirli-Talbott, Alpana Kaushiva, Harvey Risch, Steven Narod, Tian-Li Wang, Vinita Parkash, Russell Vang,[...]. Cancer Prev Res (Phila) 2018
27
14

Ovarian cancer development and metastasis.
Ernst Lengyel. Am J Pathol 2010
866
14

The 'incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention.
Paolo Vercellini, Piergiorgio Crosignani, Edgardo Somigliana, Paola Viganò, Laura Buggio, Giorgio Bolis, Luigi Fedele. Hum Reprod 2011
85
14

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
14

Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.
Benjamin G Bitler, Katherine M Aird, Azat Garipov, Hua Li, Michael Amatangelo, Andrew V Kossenkov, David C Schultz, Qin Liu, Ie-Ming Shih, Jose R Conejo-Garcia,[...]. Nat Med 2015
364
14

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman,[...]. Lancet 2010
952
14

An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy.
Ying-Qing Wang, Ping-Yuan Wang, Yu-Ting Wang, Guang-Fu Yang, Ao Zhang, Ze-Hong Miao. J Med Chem 2016
94
14

Hereditary ovarian cancer: not only BRCA 1 and 2 genes.
Angela Toss, Chiara Tomasello, Elisabetta Razzaboni, Giannina Contu, Giovanni Grandi, Angelo Cagnacci, Russell J Schilder, Laura Cortesi. Biomed Res Int 2015
82
14

Diagnosis and Management of Ovarian Cancer.
Chyke A Doubeni, Anna R Doubeni, Allison E Myers. Am Fam Physician 2016
100
14

Persistence of fimbrial tissue on the ovarian surface after salpingectomy.
Carmen Gan, Rashna Chenoy, Dhivya Chandrasekaran, Elly Brockbank, Antony Hollingworth, Sotiris Vimplis, Alexandra C Lawrence, Arjun R Jeyarajah, David Oram, Nandita Deo,[...]. Am J Obstet Gynecol 2017
15
14

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
14

Role of Fallopian Tubes in the Development of Ovarian Cancer.
Camila Corzo, Maria D Iniesta, Maria Guadalupe Patrono, Karen H Lu, Pedro T Ramirez. J Minim Invasive Gynecol 2017
19
14


Adjunct Screening With Tomosynthesis or Ultrasound in Women With Mammography-Negative Dense Breasts: Interim Report of a Prospective Comparative Trial.
Alberto S Tagliafico, Massimo Calabrese, Giovanna Mariscotti, Manuela Durando, Simona Tosto, Francesco Monetti, Sonia Airaldi, Bianca Bignotti, Jacopo Nori, Antonella Bagni,[...]. J Clin Oncol 2016
108
14

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
14

ACR Appropriateness Criteria® Ovarian Cancer Screening.
Pari V Pandharipande, Kathryn P Lowry, Caroline Reinhold, Mostafa Atri, Carol B Benson, Priyadarshani R Bhosale, Edward D Green, Stella K Kang, Yulia Lakhman, Katherine E Maturen,[...]. J Am Coll Radiol 2017
6
33

ACR Appropriateness Criteria® Breast Cancer Screening.
Martha B Mainiero, Linda Moy, Paul Baron, Aarati D Didwania, Roberta M diFlorio, Edward D Green, Samantha L Heller, Anna I Holbrook, Su-Ju Lee, Alana A Lewin,[...]. J Am Coll Radiol 2017
76
14

Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.
Su Min Ha, Eun Young Chae, Joo Hee Cha, Hak Hee Kim, Hee Jung Shin, Woo Jung Choi. AJR Am J Roentgenol 2017
25
14

Ovarian cancer in Lynch syndrome; a systematic review.
J M Helder-Woolderink, E A Blok, H F A Vasen, H Hollema, M J Mourits, G H De Bock. Eur J Cancer 2016
59
14

Hereditary breast and ovarian cancer: new genes in confined pathways.
Finn Cilius Nielsen, Thomas van Overeem Hansen, Claus Storgaard Sørensen. Nat Rev Cancer 2016
186
14

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
14

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009
345
14

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Adam N Rosenthal, Lindsay S M Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Elizabeth Benjamin, Naveena Singh,[...]. J Clin Oncol 2017
81
14

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
498
14

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.
B B J Hermsen, R I Olivier, R H M Verheijen, M van Beurden, J A de Hullu, L F Massuger, C W Burger, C T Brekelmans, M J Mourits, G H de Bock,[...]. Br J Cancer 2007
97
14

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
582
14


Mammographic density and the risk and detection of breast cancer.
Norman F Boyd, Helen Guo, Lisa J Martin, Limei Sun, Jennifer Stone, Eve Fishell, Roberta A Jong, Greg Hislop, Anna Chiarelli, Salomon Minkin,[...]. N Engl J Med 2007
14

Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.
Noriaki Ohuchi, Akihiko Suzuki, Tomotaka Sobue, Masaaki Kawai, Seiichiro Yamamoto, Ying-Fang Zheng, Yoko Narikawa Shiono, Hiroshi Saito, Shinichi Kuriyama, Eriko Tohno,[...]. Lancet 2016
214
14

Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
Glen Lo, Anabel M Scaranelo, Hana Aboras, Sandeep Ghai, Supriya Kulkarni, Rachel Fleming, Karina Bukhanov, Pavel Crystal. Radiology 2017
33
14

Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
Jan C M van Zelst, Roel D M Mus, Gwendolyn Woldringh, Matthieu J C M Rutten, Peter Bult, Suzan Vreemann, Mathijn de Jong, Nico Karssemeijer, Nicoline Hoogerbrugge, Ritse M Mann. Radiology 2017
38
14

Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
Carol H Lee, D David Dershaw, Daniel Kopans, Phil Evans, Barbara Monsees, Debra Monticciolo, R James Brenner, Lawrence Bassett, Wendie Berg, Stephen Feig,[...]. J Am Coll Radiol 2010
413
14

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Xuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, Ellen Warner, Francesco Sardanelli, Martin O Leach, Christopher C Riedl, Isabelle Trop, Maartje J Hooning, Rodica Mandel,[...]. Br J Cancer 2016
45
14

Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Wendie A Berg, Zheng Zhang, Daniel Lehrer, Roberta A Jong, Etta D Pisano, Richard G Barr, Marcela Böhm-Vélez, Mary C Mahoney, W Phil Evans, Linda H Larsen,[...]. JAMA 2012
563
14

Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter.
Susan C Modesitt, Edward J Pavlik, Frederick R Ueland, Paul D DePriest, R J Kryscio, J R van Nagell. Obstet Gynecol 2003
124
14

Spindle pole body component 25 regulates stemness of prostate cancer cells.
Feilun Cui, Huaming Tang, Jian Tan, Jianpeng Hu. Aging (Albany NY) 2018
8
12

The distinct clinicopathological and prognostic implications of PIK3CA mutations in breast cancer patients from Central China.
Haibo Wu, Wei Wang, Jun Du, Hong Li, Huogang Wang, Liangliang Huang, Hang Xiang, Jing Xie, Xiaoli Liu, Heng Li,[...]. Cancer Manag Res 2019
4
25

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Balazs Györffy, Andras Lanczky, Aron C Eklund, Carsten Denkert, Jan Budczies, Qiyuan Li, Zoltan Szallasi. Breast Cancer Res Treat 2010
7

The Ndc80 complex: integrating the kinetochore's many movements.
John Tooley, P Todd Stukenberg. Chromosome Res 2011
53
7

Spindle pole body component 25 homolog expressed by ECM stiffening is required for lung cancer cell proliferation.
Jangho Jeong, Seula Keum, Daehwan Kim, Eunae You, Panseon Ko, Jieun Lee, Jaegu Kim, Jung-Woong Kim, Sangmyung Rhee. Biochem Biophys Res Commun 2018
15
7

Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth.
Rajneesh Pathania, Sabarish Ramachandran, Gurusamy Mariappan, Priyanka Thakur, Huidong Shi, Jeong-Hyeon Choi, Santhakumar Manicassamy, Ravindra Kolhe, Puttur D Prasad, Suash Sharma,[...]. Cancer Res 2016
83
7


STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.
Damian Szklarczyk, Annika L Gable, David Lyon, Alexander Junge, Stefan Wyder, Jaime Huerta-Cepas, Milan Simonovic, Nadezhda T Doncheva, John H Morris, Peer Bork,[...]. Nucleic Acids Res 2019
7

Epigenome-based cancer risk prediction: rationale, opportunities and challenges.
Martin Widschwendter, Allison Jones, Iona Evans, Daniel Reisel, Joakim Dillner, Karin Sundström, Ewout W Steyerberg, Yvonne Vergouwe, Odette Wegwarth, Felix G Rebitschek,[...]. Nat Rev Clin Oncol 2018
60
7

Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) promotes epithelial-mesenchymal transition in breast cancer cells by regulating SPDEF/CDH1 signaling.
Bin Xiao, Zhenzhan Kuang, Weiyun Zhang, Jianfeng Hang, Lidan Chen, Ting Lei, Yongyin He, Chun Deng, Weiwei Li, Jingrun Lu,[...]. Mol Carcinog 2019
9
11

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.
Yingyao Zhou, Bin Zhou, Lars Pache, Max Chang, Alireza Hadj Khodabakhshi, Olga Tanaseichuk, Christopher Benner, Sumit K Chanda. Nat Commun 2019
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.